Download "user manual"

Transcript
ANNEX 10:
Monitoring Plan
Study Title / #: Evaluation
Xpert™ MTB / #7210 2/1
Site / Investigator
UPCH, Peru (#01) /
E. Gotuzzo
Monitor
Study coordinator: Catharina Boehme
Site
Certification
yes
no
Pamela Nabeta (PN)
x
Initial
Visit
yes
no
Site
Training
pers call
Monitor.
Visits
yes
no
x
PN
x
PN
x
PN
calls
Periodic
Contacts
e-mails
x
x
other
Cl.-Out
Visit
yes
no
x
PN
1. Site initiation visit including site training and – where required- site certification.
Site certification: Has been done for this site.
Study specific training and study initiation: PN (4-6 days). Report to be shared with Cepheid and David Alland‟s team.
Training on GeneXpert and Xpert TB assay (participants: 2 lab techs, 2 biologists and on site study coordinator; theoretical part (background, required software functions,
basic curve interpretation, trouble shooting); practical part (and proficiency testing) with 75 frozen, pre-characterized specimens.
Training on study specific tasks (e.g. clinical and laboratory workflow, blinding, other documentation (CRF, change control etc.), data entry, GeneXpert data management.
Study initiation: Study workflow as outlined in protocol, testing of fresh samples.
2. Monitoring visits: 2 visits during enrolment. 5 % of data entry fields to be compared with CRFs for QA of data management.
3. Calls: Once monthly: CB & PN (FIND) & on site study coordinator (UPCH). Cepheid and David Alland‟s team will be asked by CB to participate in case of GeneXpert
related technical changes, problems or unexpected events/observations.
4. E-mails: Xpert data to be mailed to Cepheid as .gxx files on a monthly basis. Progress reports will be sent at least on a monthly basis (database will allow to generate those
automatically). Cepheid will be copied on all emails with Xpert related questions/topics.
5. Close out visit: 2 months after end of enrolment. Preliminary excel data sheets to be provided by site at the end of enrolment (culture and DST results pending) and final
excel sheet after completion of culture/DST results. CRF copies to be provided to Cepheid and FIND. Final study report to be provided by CB.
South African sites
Pamela Nabeta (PN)
x
x
x
x
x
x
x
HA
CB
CB
HA
CB
Hinduja Hospital, India
TBD
FZ Borstel
Catharina Boehme (CB)
X
CNP
x
x
CB
x
CB
x
TBD
x
x
x
TBD
x
CB
x
CB
x
PN
x
x
x
CB
63